Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy NuVasive stock

Learn how to easily invest in NuVasive stock.

NuVasive Inc is a medical devices business based in the US. NuVasive shares (NUVA) are listed on the NASDAQ and all prices are listed in US Dollars. NuVasive employs 2,900 staff and has a trailing 12-month revenue of around $1.2 billion.

How to buy shares in NuVasive

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NUVA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

NuVasive stock price (NASDAQ: NUVA)

Use our graph to track the performance of NUVA stocks over time.

NuVasive shares at a glance

Information last updated 2022-10-03.
Latest market close$43.96
52-week range$41.33 - $62.83
50-day moving average $48.10
200-day moving average $51.64
Wall St. target price$59.92
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.72

Buy NuVasive shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NuVasive stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NuVasive price performance over time

Historical closes compared with the close of $43.96 from 2022-10-03

1 week (2022-09-28) -1.08%
1 month (2022-09-02) 1.41%
3 months (2022-07-05) -12.71%
6 months (2022-04-05) -19.78%
1 year (2021-10-05) -26.71%
2 years (2020-10-05) -9.58%
3 years (2019-10-04) 64.52
5 years (2017-10-05) 56.46

Is NuVasive stock undervalued or overvalued?

Valuing NuVasive stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NuVasive's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

NuVasive's PEG ratio

NuVasive's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7855. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NuVasive's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

NuVasive's EBITDA

NuVasive's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $193.6 million.

The EBITDA is a measure of a NuVasive's overall financial performance and is widely used to measure a its profitability.

NuVasive financials

Revenue TTM $1.2 billion
Operating margin TTM 4.85%
Gross profit TTM $816.7 million
Return on assets TTM 1.65%
Return on equity TTM -4.81%
Profit margin -3.41%
Book value $15.88
Market capitalisation $2.3 billion

TTM: trailing 12 months

NuVasive share dividends

We're not expecting NuVasive to pay a dividend over the next 12 months.

NuVasive share price volatility

Over the last 12 months, NuVasive's shares have ranged in value from as little as $41.33 up to $62.83. A popular way to gauge a stock's volatility is its "beta".

NUVA.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NuVasive's is 1.1786. This would suggest that NuVasive's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

NuVasive overview

NuVasive, Inc. , a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc.

Frequently asked questions

What percentage of NuVasive is owned by insiders or institutions?
Currently 0.228% of NuVasive shares are held by insiders and 106.702% by institutions.
How many people work for NuVasive?
Latest data suggests 2,900 work at NuVasive.
When does the fiscal year end for NuVasive?
NuVasive's fiscal year ends in December.
Where is NuVasive based?
NuVasive's address is: 7475 Lusk Boulevard, San Diego, CA, United States, 92121
What is NuVasive's ISIN number?
NuVasive's international securities identification number is: US6707041058
What is NuVasive's CUSIP number?
NuVasive's Committee on Uniform Securities Identification Procedures number is: 670704105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site